City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
July 10, 2017 | Katie Neith
According to a new article in Nature, a team led by City of Hope’s Markus Müschen, M.D., Ph.D., Chair of the Department of Systems Biology, thinks that sugar uptake and energy supply may play a key role in the relapse of ALL.
July 5, 2017 | Michael Easterling
The African bull elephant is the largest mammal on the planet, comprised of trillions of cells that should ostensibly be a breeding ground for cancer. But because of an evolutionary anomaly, elephants don’t get cancer, a fact that fascinates Markus Müschen, M.D., Ph.D.
June 2, 2017 | Letisia Marquez
City of Hope physicians and researchers are headed to Chicago to present groundbreaking research on blood stem cell transplants for HIV patients, immunotherapies, unique treatment options for older adults battling breast cancer and other topics during the American Society of Clinical Oncology’s (ASCO) 2017 Annual Meeting June 2 to 6.
May 12, 2017 | Samantha Bonar
Nine months after her daughter’s birth, Monica Weld got a bad sore throat and cough that she just couldn’t shake. She and her husband went directly to the hospital, where tests showed she had not one, but two kinds of leukemia: acute lymphoblastic (ALL) and acute myeloid (AML).
February 14, 2017 | Abe Rosenberg
Hailed as one of the best researchers of his generation, Markus Müschen, M.D., Ph.D., has joined City of Hope with the singular goal of wiping out Acute Lymphoblastic Leukemia (ALL), the most common form of cancer in children.
September 15, 2016 | Michael Easterling
Ivan Garcia-Burgos was a typical 21-year-old: hanging out with friends, working on his beloved sports car and playing team volleyball. Yet at a time in life that should be about hope for the future, Ivan had to confront the cold reality that he may not have one - he was diagnosed with Acute Lymphoblastic Leukemia.
March 2, 2015 | Sumanta Kumar Pal M.D.
Pick up any biotech industry report and you’re guaranteed to come across one term repeatedly – CAR-T therapy. A fierce competition is now underway to bring CAR-T treatments to market – several companies (Juno, Novartis, Kite and Cellectis, to name a few) have major stakes in the race.
September 24, 2014 | rdarakjian
Rob Darakjian , a former leukemia patient, shares tips on how to overcome anxiety and depression while being treated for cancer. Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old.
July 7, 2014 | Roberta Nichols
John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission.
June 5, 2014 | Nicole White
A quarter of children in remission from acute lymphoblastic leukemia, or ALL, are tripling their risk of a relapse because they are missing too many doses of an essential maintenance medication, according to findings from a recent City of Hope study .
Load MoreBack To Top